PBT2 further development!, page-5

i really like this bit which shows just how much development Alterity has put into the PBT2 drug - it has the potential be a blockbuster and clearly the scientists recognize the value already. I dont not think pbt2 has been factored at all into current share price:

“Based on its use as an experimental Alzheimer’s treatment, there’s been a significant amount of solid science done on this drug already,” Prof von Itzstein said.“We know, for example, that clinical studies of PBT2 show that it is safe for use in humans.“And, given that we’ve been able to combine it with the antibiotic polymyxin to treat polymyxin-resistant bacteria, we may be able to make other now-ineffective antibiotics become effective again for treating infectious diseases.“This could resharpen, so to speak, some of the weapons we thought we’d lost in our fight against antibiotic-resistant bacteria.”